Morton Grove Recalls Lindane Lotion Due to Out-of-Specification Assay
Morton Grove Pharmaceuticals is recalling specific lots of Lindane Lotion because stability samples failed assay testing. Consumers should stop using the product and return it to their pharmacy.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which is defined as unlikely to cause adverse health consequences. The issue is a quality control failure (assay) rather than a direct safety hazard like contamination or mislabeling of a common allergen.
Plain-English summary
Morton Grove Pharmaceuticals, Inc. is recalling 39,187 bottles of Lindane Lotion, USP 1%, 2 fl oz (60 mL). The recall affects products with NDC 60432-833-60, specifically Lot UP1103 (Exp 04/2016) and Lot UQ1001 (Exp 04/2017). The product was distributed nationwide and in Puerto Rico.
The recall was initiated because out-of-specification assay test results were reported for stability samples. This indicates that the concentration of the active ingredient in the recalled lots may not meet the required standards.
Consumers who have this product should stop using it and return it to their pharmacy or point of purchase for a refund or replacement. Patients should consult their healthcare provider for alternative treatment options if necessary.
The recalled product
- Product
- Lindane Lotion, USP 1%, For External use Only, Rx Only, 2 fl oz (60 mL) bottle, MGP, NDC 60432-833-60
- Manufacturer
- Morton Grove Pharmaceuticals, Inc.
- Affected units
- 39,187
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: UP1103
- Exp 04/2016
- UQ1001
- Exp 04/2017
Distribution
Related recalls
Same manufacturer · Morton Grove Pharmaceuticals, Inc.
See all →- ModerateDexamethasone Elixir Recalled for Impurities Above Permissible Levels
FDA (Drugs) · 2022-03-09
- HighPromethazine With Codeine Oral Solution Recall Due to Microbial Contamination
FDA (Drugs) · 2021-09-29
- ModerateValproic Acid Oral Solution recalled for microbial contamination
FDA (Drugs) · 2021-09-29
- ModeratePromethazine Syrup Plain Recall Due to Microbial Contamination
FDA (Drugs) · 2021-09-29
- SevereMorton Grove Recalls Hydroxyzine Hydrochloride Oral Solution Due to Impurities
FDA (Drugs) · 2020-12-30
Same hazard · quality control
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateDuoGlide Short-Term Dialysis Catheter recall due to deficient manufacturing
FDA (Devices) · 2026-07-08
- ModeratedirectCHECK whole blood control labeled with incorrect performance range
FDA (Devices) · 2026-06-24
- HighAmyloid plasma controls recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11
- HighpTau 217 plasma controls recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11